Apyx Medical Corporation (APYX)
NASDAQ: APYX
· Real-Time Price · USD
2.17
0.05 (2.36%)
At close: Aug 15, 2025, 3:59 PM
2.16
-0.69%
After-hours: Aug 15, 2025, 04:10 PM EDT
Apyx Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.74M | -4.15M | -4.66M | -4.77M | -6.56M | -7.58M | -9.61M | -4.67M | -1.02M | -3.53M | -6.07M | -5.79M | -5.45M | -5.97M | -2.01M | -4.23M | -4.05M | -4.91M |
Depreciation & Amortization | 132K | 138K | 142K | 144K | 156K | 157K | 152K | 186K | 151K | 203K | 202K | 216K | 247K | 225K | 229K | 234K | 213K | 227K |
Stock-Based Compensation | 520K | 451K | 838K | 997K | 1.05M | 1.13M | 914K | 1.35M | 1.48M | 1.37M | 1.64M | 1.69M | 1.71M | 1.65M | 1.34M | 1.18M | 1.37M | 1.19M |
Other Working Capital | 309K | -819K | 403K | 42K | 328K | -1.33M | 1.94M | 7.92M | -1.44M | -940K | 326K | 400K | -1.63M | -729K | 3.18M | 2.19M | -942K | 336K |
Other Non-Cash Items | 560K | 266K | 1.14M | -428K | 321K | 265K | 7.79M | 179K | 164K | -75K | 111K | 47K | 219K | 251K | 484K | 60K | 53K | 6K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.96M | 208K | -2.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.29M | 2.59M | -394K | -385K | 700K | -315K | 2.25M | 6.45M | -3.31M | 156K | -419K | -1.52M | -2.6M | -676K | 170K | -849K | -2.59M | 1.43M |
Operating Cash Flow | -1.23M | -702K | -2.94M | -4.44M | -4.33M | -6.34M | -458K | 3.7M | -4.85M | -1.88M | -4.53M | -5.36M | -5.87M | -4.52M | 214K | -3.6M | -5.01M | -2.05M |
Capital Expenditures | -265K | -55K | -245K | -153K | -289K | -35K | -93K | -174K | -156K | -110K | -142K | -188K | -401K | -279K | -332K | -170K | -29K | -192K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -7.41M | 147K | 7.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 195K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 7.41M | -147K | 7.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -265K | -55K | -245K | -153K | -289K | -35K | -93K | -174K | 7.11M | -110K | -142K | -188K | -401K | -279K | -332K | -170K | -29K | -192K |
Debt Repayment | -5K | -5K | -5K | -5K | -5K | -5K | 20.04M | -13K | -10K | 9.28M | -10K | -30K | -54K | -54K | -57K | -61K | -38K | -82K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 30K | 30K | -11K | n/a | n/a | n/a | n/a | 147K | 1.81M | -1.17M | n/a | 157K | 56K | 152K | 18K | 28K | 195K | 21K |
Financial Cash Flow | 25K | 25K | 6.76M | -5K | -5K | -5K | 22.09M | 164K | 46K | 8.11M | -10K | 127K | 2K | 98K | -39K | -33K | 157K | -61K |
Net Cash Flow | -1.71M | -730K | 3.73M | -4.67M | -4.6M | -6.37M | 21.52M | 3.65M | 2.22M | 6.06M | -4.64M | -5.23M | -6.17M | -4.64M | -28K | -3.77M | -4.87M | -2.38M |
Free Cash Flow | -1.5M | -757K | -3.18M | -4.59M | -4.62M | -6.38M | -551K | 3.52M | -5.01M | -1.99M | -4.67M | -5.55M | -6.27M | -4.8M | -118K | -3.77M | -5.04M | -2.24M |